simvastatin has been researched along with Chronic Kidney Diseases in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (10.53) | 29.6817 |
| 2010's | 32 (84.21) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Cass, A; Gallagher, M; Hooi, L; Jardine, M; Jun, M; Rogers, K; Smyth, B; Sukkar, L; Talbot, B; Walker, R | 1 |
| Adorni, MP; Biancorosso, N; Bressan, A; Brilli, E; Chen, H; Dall'Acqua, S; Faggin, E; Ferri, N; Lupo, MG; Neutel, C; Rattazzi, M; Salvalaio, M; Sut, S; Tarantino, G; Vivian, G | 1 |
| Bonsu, KO; Buabeng, KO; Kadirvelu, A; Owusu, IK; Reidpath, DD | 1 |
| Assaretti, S; Baralla, A; Carru, C; Mangoni, AA; Satta, AE; Sotgia, S; Sotgiu, E; Zinellu, A | 1 |
| Geng, Q; Guo, L; Liu, Y; Liu, Z; Ma, H; Wang, P; Xie, H; Zhan, H; Zhang, G | 1 |
| Ding, G; Ma, Y; Yang, J; Yang, Q; Yang, Y | 1 |
| Vogt, L; Waters, DD | 1 |
| Dogrammatzi, F; Efstratiadis, G; Kirmizis, D; Memmos, D; Papagianni, A | 1 |
| Ikemori, A; Kimura, K | 1 |
| Baigent, C; Blackwell, L; Emberson, J; Fellström, B; Haynes, R; Herrington, W; Hooi, LS; Landray, MJ; Levin, A; Massy, ZA; Reith, C; Staplin, N; Tesar, V; Walker, R | 1 |
| Almquist, T; Hjemdahl, P; Jacobson, SH; Mobarrez, F; Näsman, P | 1 |
| Cavasin, MA; Chonchol, M; Demos-Davies, KM; Jablonski, K; Keenan, AL; Kendrick, J; Levi, M; Masuda, M; Masuda, R; McKinsey, TA; Miyazaki, M; Miyazaki-Anzai, S; Saunders, SJ | 1 |
| Chung, W; Han, KH; Hwang, YH; Jo, SK; Kim, HJ; Kim, SG; Lee, CH; Oh, KH; Song, YR; Yi, YJ | 1 |
| Apanasovich, N; Dosta, N; Locatelli, F; März, W; Varushchanka, A; Wanner, C; Yakubtsevich, R | 1 |
| Carru, C; Mangoni, AA; Sanna, M; Satta, AE; Sotgia, S; Zinellu, A | 1 |
| Asif, A; Boden, WE; de Boer, IH; Ix, JH; Kalil, RS; Mathew, RO; Shi, X; Wang, JH | 1 |
| Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP | 1 |
| Koskinen, PK; Palin, NK; Rintala, JM; Savikko, J | 1 |
| Baigent, C; Cass, A; Emberson, J; Gray, A; Haynes, R; Herrington, W; Landray, MJ; Mihaylova, B; Morton, RL; Schlackow, I; Staplin, N | 1 |
| Almquist, T; Hjemdahl, P; Jacobson, SH; Mobarrez, F; Wallén, H | 1 |
| Baigent, C; Cass, A; Collins, R; Craig, J; Emberson, J; Gray, A; Haynes, R; Herrington, W; Kent, S; Landray, MJ; Lozano-Kühne, J; Mihaylova, B; Reith, C; Schlackow, I | 1 |
| Cavanaugh, KL; Fagerlin, A; Wright Nunes, JA | 1 |
| Butler, CR; O'Hare, AM | 1 |
| Carru, C; Ena, S; Mangoni, AA; Satta, AE; Sotgia, S; Sotgiu, E; Zinellu, A | 1 |
| Agodoa, L; Baigent, C; Emberson, J; Haynes, R; Herrington, W; Judge, PK; Landray, MJ; Lewington, S; Mafham, M; Reith, CA; Staplin, N; Tomson, C; Walker, R; Wheeler, DC; Wiecek, A | 1 |
| Pazianas, M | 1 |
| Blazing, MA; Califf, RM; de Lemos, JA; Fox, K; Lewis, EF; Mielniczuk, LM; Mohanavelu, S; Pedersen, TR; Pfeffer, MA; Rouleau, J | 1 |
| Jardine, AG; Stevens, KK | 1 |
| Agodoa, L; Armitage, J; Baigent, C; Baxter, A; Bray, C; Cass, A; Chen, Y; Chen, Z; Collins, R; Craig, J; Dasgupta, T; de Zeeuw, D; Emberson, J; Feldt-Rasmussen, B; Fellström, B; Gaziano, M; Grimm, R; Grobbee, D; Grönhagen-Riska, C; Herrington, W; Hill, M; Holdaas, H; Hooi, LS; Jiang, L; Kasiske, B; Knott, C; Krairittichai, U; Krane, V; Landray, MJ; Levin, A; Lewis, D; Mafham, M; Majoni, W; Massy, ZA; Neal, B; Ophascharoensuk, V; Parish, S; Pedersen, T; Reith, C; Simpson, D; Sleight, P; Tesar, V; Tobert, J; Tomson, C; Walker, R; Wallendszus, K; Wanner, C; Wheeler, DC; Wiecek, A; Young, A | 1 |
| Lui, P | 1 |
| Goldstein, MR; Mascitelli, L | 1 |
| Al-Rasadi, K; Banerjee, Y | 1 |
| Abejón, L; Aguila, E; Bernal, D; de Tena, JG; Rodríguez-Zapata, M | 1 |
| Laville, M | 1 |
| Green, D; McDonald, J; O'Riordan, E; Panayotova, R; Ritchie, JP | 1 |
| Carru, C; Deiana, L; Loriga, G; Pisanu, E; Satta, AE; Sotgia, S; Zinellu, A | 1 |
| Chonchol, M; Cook, T; Kjekshus, J; Lindenfeld, J; Pedersen, TR | 1 |
| Dold, S; Espinoza, LR; Justiniano, M | 1 |
3 review(s) available for simvastatin and Chronic Kidney Diseases
| Article | Year |
|---|---|
[Clinical significance of treatment for dyslipidemia in CKD].
Topics: Azetidines; Cardiovascular Diseases; Cholesterol; Disease Progression; Drug Combinations; Dyslipidemias; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Glomerulus; Kidney Tubules; Lipoproteins; Renal Insufficiency, Chronic; Risk Factors; Simvastatin | 2013 |
Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
Topics: Acute Kidney Injury; Atorvastatin; Cardiovascular Diseases; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Risk; Rosuvastatin Calcium; Simvastatin | 2015 |
Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?
Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Drug Therapy, Combination; Ezetimibe; Humans; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin | 2012 |
16 trial(s) available for simvastatin and Chronic Kidney Diseases
| Article | Year |
|---|---|
Comparing survival in patients with chronic kidney disease across three countries - Results from the study of heart and renal protection-extended review.
Topics: Ezetimibe; Humans; Kidney; Kidney Transplantation; Renal Insufficiency, Chronic; Simvastatin | 2023 |
Cholesterol lowering treatment restores blood global DNA methylation in chronic kidney disease (CKD) patients.
Topics: 5-Methylcytosine; Aged; Allantoin; Biomarkers; Cholesterol; DNA Methylation; Down-Regulation; Ezetimibe, Simvastatin Drug Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Insufficiency, Chronic; Simvastatin; Time Factors; Treatment Outcome; Uric Acid | 2017 |
Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis.
Topics: Aged; Anti-Inflammatory Agents; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin; Vascular Cell Adhesion Molecule-1 | 2013 |
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
Topics: Aged; Anticholesteremic Agents; Azetidines; Catheterization; Cholesterol, LDL; Device Removal; Drug Therapy, Combination; Ezetimibe; Female; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Reoperation; Simvastatin; Thrombosis; Vascular Access Devices; Vascular Patency | 2014 |
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.
Topics: Aged; Anticholesteremic Agents; Azetidines; Case-Control Studies; Chemokine CCL2; Cross-Over Studies; Diabetes Mellitus; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Inflammation; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Renal Insufficiency, Chronic; Simvastatin; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2014 |
Comparison of the efficacy and safety profile of morning administration of controlled-release simvastatin versus evening administration of immediate-release simvastatin in chronic kidney disease patients with dyslipidemia.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Simvastatin; Treatment Outcome; Triglycerides | 2014 |
Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients.
Topics: Adult; Aged; Bile Acids and Salts; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Europe; Female; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin; Time Factors; Treatment Outcome; Triglycerides | 2014 |
Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Topics: Aged; Allantoin; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Ezetimibe; Female; Healthy Volunteers; Humans; Inflammation; Kynurenine; Male; Malondialdehyde; Middle Aged; NF-kappa B; Oxidative Stress; Renal Insufficiency, Chronic; Simvastatin; Taurine; Triglycerides; Tryptophan; Uric Acid | 2015 |
Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Cholesterol, HDL; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Renal Insufficiency, Chronic; Secondary Prevention; Simvastatin; Triglycerides | 2015 |
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
Topics: Aged; Anticholesteremic Agents; Disease Progression; Educational Status; Ezetimibe; Female; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Severity of Illness Index; Simvastatin; Vascular Diseases | 2016 |
Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.
Topics: Aged; Anticholesteremic Agents; Biomarkers; Cardiovascular Diseases; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Renal Insufficiency, Chronic; Risk Factors; Simvastatin | 2016 |
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
Topics: Aged; Anticholesteremic Agents; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Therapy, Combination; Ezetimibe; Female; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Simvastatin | 2016 |
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.
Topics: Aged; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Risk Factors; Simvastatin | 2017 |
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Topics: Adult; Aged; Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Kidney Function Tests; Male; Middle Aged; Reference Values; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Severity of Illness Index; Simvastatin; Survival Analysis; Time Factors; Treatment Outcome | 2011 |
LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy.
Topics: Allantoin; Apolipoproteins B; Azetidines; Cholesterol, LDL; Drug Combinations; Dyslipidemias; Ezetimibe, Simvastatin Drug Combination; Female; Homocystine; Humans; Hypolipidemic Agents; Lipid Metabolism; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Renal Insufficiency, Chronic; Simvastatin; Sulfhydryl Compounds; Uric Acid | 2012 |
Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
Topics: Adult; Aged; Anticholesteremic Agents; Coronary Disease; Double-Blind Method; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Renal Insufficiency, Chronic; Risk Factors; Scandinavian and Nordic Countries; Simvastatin | 2007 |
19 other study(ies) available for simvastatin and Chronic Kidney Diseases
| Article | Year |
|---|---|
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line.
Topics: Acyl Coenzyme A; Adenine; Animals; Anticholesteremic Agents; Cell Line, Tumor; Cholesterol; Cysteine; Dietary Supplements; Humans; Hypercholesterolemia; Iron; Magnesium; Male; Rats, Sprague-Dawley; Receptors, LDL; Renal Insufficiency, Chronic; Simvastatin; Uremia; Vascular Calcification | 2020 |
Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis.
Topics: Aged; Atorvastatin; Atrial Fibrillation; Black People; Cardiomyopathy, Dilated; Cardiovascular Diseases; Cause of Death; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Fatty Acids, Monounsaturated; Fluvastatin; Ghana; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indoles; Kaplan-Meier Estimate; Longitudinal Studies; Middle Aged; Mortality; Multivariate Analysis; Probability; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Rosuvastatin Calcium; Simvastatin; Treatment Outcome | 2017 |
The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.
Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Diabetes Mellitus; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Function Tests; Logistic Models; Male; Middle Aged; Percutaneous Coronary Intervention; Renal Insufficiency, Chronic; Simvastatin; Time Factors | 2017 |
Angiotensin II induces cholesterol accumulation and injury in podocytes.
Topics: Angiotensin II; Animals; Apoptosis; Cholesterol; Cytoskeleton; Disease Models, Animal; Gene Expression; Lipid Metabolism; Perilipin-2; Podocytes; Renal Insufficiency, Chronic; Simvastatin | 2017 |
Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Drug Therapy, Combination; Humans; Inflammation; Lipids; Renal Insufficiency, Chronic; Simvastatin; Treatment Outcome | 2018 |
Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease-induced vascular calcification.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Azetidines; Calcinosis; Cardiovascular Diseases; Case-Control Studies; Drug Therapy, Combination; Endoplasmic Reticulum; Ezetimibe; Humans; Ketocholesterols; Lipids; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Renal Insufficiency, Chronic; Simvastatin; Transcription Factor CHOP; Vascular Diseases | 2014 |
Intensive perioperative simvastatin treatment protects from chronic kidney allograft injury.
Topics: Allografts; Animals; Creatinine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Transplantation; Perioperative Care; Proteinuria; Rats; Renal Insufficiency, Chronic; Reperfusion Injury; Simvastatin; Tissue Donors; Transplant Recipients | 2015 |
An Informed and Activated Patient: Addressing Barriers in the Pathway From Education to Outcomes.
Topics: Anticholesteremic Agents; Educational Status; Ezetimibe; Female; Humans; Male; Renal Insufficiency, Chronic; Simvastatin | 2016 |
Considerations in Applying the Results of Randomized Controlled Clinical Trials to the Care of Older Adults With Kidney Disease in the Clinical Setting: The SHARP Trial.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Clinical Decision-Making; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Health Services for the Aged; Humans; Male; Middle Aged; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Simvastatin | 2016 |
Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease.
Topics: Allantoin; Anticholesteremic Agents; Arginine; Biomarkers; Cholesterol; Endothelium; Ezetimibe; Female; Humans; Inflammation; Kynurenine; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Insufficiency, Chronic; Simvastatin; Uric Acid | 2016 |
Calcific aortic stenosis.
Topics: Animals; Anticholesteremic Agents; Aortic Valve Stenosis; Atherosclerosis; Azetidines; Calcinosis; Disease Progression; Ezetimibe; Humans; Models, Biological; Renal Insufficiency, Chronic; Simvastatin | 2009 |
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; C-Reactive Protein; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypolipidemic Agents; Inflammation; Kaplan-Meier Estimate; Kidney Function Tests; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Risk Factors; Simvastatin; Treatment Outcome | 2009 |
SHARP: a stab in the right direction in chronic kidney disease.
Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Drug Therapy, Combination; Ezetimibe; Female; Humans; Male; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin; Treatment Outcome | 2011 |
Benefits of lowering cholesterol in chronic kidney disease.
Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Male; Renal Insufficiency, Chronic; Simvastatin | 2011 |
Benefits of lowering cholesterol in chronic kidney disease.
Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Male; Renal Insufficiency, Chronic; Simvastatin | 2011 |
Benefits of lowering cholesterol in chronic kidney disease.
Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Male; Renal Insufficiency, Chronic; Simvastatin | 2011 |
Benefits of lowering cholesterol in chronic kidney disease.
Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Male; Renal Insufficiency, Chronic; Simvastatin | 2011 |
ACP Journal Club. Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney disease.
Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Male; Renal Insufficiency, Chronic; Simvastatin | 2011 |
Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine.
Topics: Arthritis, Gouty; Bursitis; Colchicine; Drug Synergism; Female; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Renal Insufficiency, Chronic; Rhabdomyolysis; Simvastatin | 2007 |